Navigation Links
Best Practices, LLC Research Highlights Critical Role of Medical Affairs in New Product Launch Success
Date:1/14/2011

CHAPEL HILL, N.C., Jan. 14, 2011 /PRNewswire/ -- New Product Planning (NPP) groups play a vital role in many of the new product development activities that set the stage for a successful launch. One of the areas of growing importance for NPP groups is medical affairs activities such as ad boards, and thought leader identification and education.

The Best Practices, LLC benchmarking report New Product Planning: Role and Activities for Medical Affairs provides a detailed examination of the timing and value of Medical Affairs activities.

Key chapters in this 50-slide report are:

  • The current state of New Product Planning in pharma 

The central challenge is to ensure that the right new products get developed efficiently—with minimum risk and maximum value—to allow senior management to make smart decisions confidently.  

  • Overview of New Product Planning activities and timing during development process

Reviews Key Patterns and Activities that drive the New Product Planning process

Pre-clinical through Phase II: NPP engages in a series of activities from Pre-Clinical through Phase 2 designed to determine the market fit and potential of identified candidates and to prepare for key activities, such as positioning and branding.

Phase III through Commercial Handoff: After Phase II, NPP activities are more focused as more clinical data becomes available and outputs are refined to support critical commercial activities and maximize the product's launch and lifecycle success.  

This chapter also reviews the main Medical Affairs activities carried out during the development process - analysis provides drill down for each of these activities in terms of their timing, intended outcomes, and value for the organization

  • Advisory Boards
  • Branding of the Science
  • KOL Identification
  • KOL Management
  • Medical Meeting Planning
  • Non-Registration Trials Strategy and Planning
  • Publication Strategy & Planning  

To download a complimentary study excerpt, go to: http://www3.best-in-class.com/rr1038.htm.

Best Practices, LLC used both field surveys and interviews to complete this study. In all, 27 New Product Planning leaders at 25 pharma companies across the globe contributed data. In-depth interviews were conducted with leaders from 13 of the participating companies.

ABOUT BEST PRACTICES, LLC

Best Practices, LLC serves 48 of the world's 50 top pharmaceutical companies.  For 17 years, we have conducted work based on the simple yet profound principle that organizations can chart a course to superior economic performance by studying the best business practices, operating tactics and winning strategies of world-class companies. 


'/>"/>
SOURCE Best Practices, LLC
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. New Research from Best Practices, LLC can Improve Formulary Access and Product Placement for Biopharma Companies: Managed Markets Market Research
2. As Biopharma Companies Reshape Sales Model, Most See Resetting Territory Size and Implementing Individualized Call Plans as First Steps Toward Change, According to New Research From Best Practices, LLC
3. New Research from Best Practices, LLC Helps Medical Device Companies Earn the Highest Profit Possible During Their Products Patent Lifecycle
4. Research from Best Practices, LLC Delivers Blueprint for Commercial Success of New Product Planning Groups
5. Best Practices, LLC Report on Post-Marketing Surveillance Programs Sheds Light on Gray Areas of Adverse Event Reporting
6. Best Practices, LLC Research Highlights Critical Role of Medical Marketing in New Product Launch Success
7. Best Practices, LLC Research Highlights Evolving Role of Market Research in Organizational Success
8. Research from Best Practices, LLC Delivers Effective Market Education Tactics and Strategies for New Oncology Products
9. The Multiple Myeloma Research Consortium (MMRC) and Proteolix Initiate Phase 2 Clinical Trial Investigating Carfilzomib for the Treatment of Multiple Myeloma
10. Multiple Myeloma Research Consortium (MMRC) Partners with Novartis to Advance Phase II Study of Deacetylase Inhibitor
11. Lexicon to Present Research Results at American Chemical Society Meeting Regarding Target of LX1031 Drug Candidate
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/24/2017)... NEW YORK , Feb. 24, 2017 ... Monteverde & Associates PC , a boutique securities ... New York City , announces that a ... of Massachusetts  against Inotek Pharmaceuticals ... purchasers of the Company,s securities between July 23, 2015 and ...
(Date:2/24/2017)... Australien, 24. Februar 2017 ITL Limited, ... des Gesundheitsbereiches, ist erfreut, für das zum 31. ... entsprechenden Vorjahreszeitraum exzellente Ergebnisse vorlegen zu können. Eine ... zum Wachstum" finden Sie hier . ... nach Steuern 2,12 Millionen USD (Dez. 2015: 1,04 Millionen USD; +104 %) ...
(Date:2/24/2017)... 2017  This report analyzes the worldwide markets for ... Products: Intermediates, Analytical, and Others. The End ... and Agrochemicals. The report provides separate comprehensive analytics for ... Europe , and Rest of World. Annual estimates ... 2022. Also, a six-year historic analysis is provided for ...
Breaking Medicine Technology:
(Date:2/24/2017)... ... 24, 2017 , ... Healthcare Associates of McKinney announced today that ... at 8080 State Highway 121, Suite 210, McKinney, Texas 75070. It is in ... , As the practice has grown, the need for more space has been paramount. ...
(Date:2/24/2017)... ... February 24, 2017 , ... The International Association of Eating Disorders Professionals ... What You See” body image mannequin art competition. Selected from 15 submissions from around ... winner revealed at the 31st annual iaedp Symposium, March 22 – 26 in Las ...
(Date:2/24/2017)... ... 24, 2017 , ... Castle Farms, the celebrated Northern ... with the winning couple announced on Feb. 14, 2017, on Facebook. The free ... vendors: A Matter of Taste, Ryan Rousseau Enterprises, A Touch of Spring and ...
(Date:2/23/2017)... ... 2017 , ... Rare Disease Report®, which is the only ... Disease Day events, hosted by the Rare Disease Legislative Advocates (RDLA) on February ... e-newsletter and quarterly publication, will be conducting interviews with patients and advocates in ...
(Date:2/23/2017)... ... February 23, 2017 , ... EBSCO Information Services ... Institute for Health and Care Excellence (NICE) framework. The agreement allows purchasers ... (NHS) to search, order and purchase medical and healthcare-related content through GOBI ...
Breaking Medicine News(10 mins):